Bradley Hardiman
SPEX
Bradley is a seasoned investment and technology commercialisation executive with 20 years’ pharmaceutical, life science, knowledge transfer and investment experience, including with a world-class university.
He is the Senior Director at Astellas Europe, scouting and evaluating opportunities for the group. These include partnerships and collaborations, in-licensing, VC investment, M&A and fund of funds. He is adept at assimilating information – leveraging a scientific background with commercial experience to create the optimal strategy for a start-up company.
He has sat on the boards of several exciting, innovative and entrepreneurial early stage companies. Helping them develop their business to grow and scale.
Bradley is a Visiting Business Fellow of InnovationRCA.
Bradley has an MBA from CASS Business School, a Master’s in Molecular Biochemistry from the University of Cambridge and a Bachelor’s degree in Medical Biochemistry from the University of Brunel.
Bradley Hardiman
SPEX
Bradley is a seasoned investment and technology commercialisation executive with 20 years’ pharmaceutical, life science, knowledge transfer and investment experience, including with a world-class university.
He is the Senior Director at Astellas Europe, scouting and evaluating opportunities for the group. These include partnerships and collaborations, in-licensing, VC investment, M&A and fund of funds. He previously was a Partner with Adrenaline, a deep tech healthcare fund. Adept at assimilating information – leveraging a scientific background with commercial experience to create the optimal strategy for a start-up company.
Bradley is a Visiting Business Fellow of InnovationRCA, was Board Observer of Healthera, Managing Partner of Future Care Capital Investment Fund and Investment Director of Cambridge Enterprise.
Bradley has an MBA from CASS Business School, a master’s in molecular biochemistry from the University of Cambridge and a bachelor’s degree in medical biochemistry from the University of Brunel.
